Binaya Jaya is primarily engaged in pharmaceuticals activity. Its headquarters is located in Sulawesi Selatan. The company was founded in 1994. Binaya Jaya was founded by Dr. Andi Rahmat and Dr. Siti Nurhaliza, who envisioned creating a leading pharmaceutical company in Indonesia. The company focuses on the development, manufacturing, and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and health supplements. Binaya Jaya operates several branches across Indonesia, with a strong presence in major cities such as Jakarta, Surabaya, and Medan. The company has expanded its operations to include a state-of-the-art manufacturing facility in Makassar, which adheres to international quality standards. The company's primary product lines include cardiovascular drugs, antibiotics, and pain management medications. Binaya Jaya's flagship brands, such as CardioPlus and PainRelief, are well-recognized in the Indonesian market. In addition to its domestic operations, Binaya Jaya exports its products to several Southeast Asian countries, including Malaysia, Thailand, and the Philippines. The company is actively seeking to expand its global footprint by entering new markets in Africa and the Middle East. Binaya Jaya has established strategic partnerships with international pharmaceutical companies to enhance its research and development capabilities. The company is a member of the Indonesian Pharmaceutical Association and participates in various industry forums to stay at the forefront of pharmaceutical innovation. With a commitment to improving healthcare outcomes, Binaya Jaya's mission is to provide high-quality, affordable medications to enhance the well-being of communities across Indonesia and beyond.
Headquarters
Kota Makassar Ballaparang Rappocini Sulawesi Selatan
Makassar; South Sulawesi;
Postal Code: 90222
Contact Details: Purchase the PT Binaya Jaya report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service